Cargando…
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma
Autores principales: | Asher, Samir, Kazantzi, Aikaterini, Dekaj, Fatjon, Steventon, Luke, Khatun, Aisha, Ainley, Louise, McMillan, Annabel, Rabin, Neil, Wechalekar, Ashu, Sive, Jonathan, Kyriakou, Charalampia, Papanikolaou, Xenofon, Xu, Ke, Mahmood, Shameem, Wisniowski, Brendan, Lee, Lydia, Yong, Kwee, Popat, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713550/ https://www.ncbi.nlm.nih.gov/pubmed/36005557 http://dx.doi.org/10.3324/haematol.2022.281322 |
Ejemplares similares
-
PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
por: Sridhar, Amrutha, et al.
Publicado: (2023) -
OAB-047: Plasma cell disorder patients are left vulnerable after one dose of the BNT162b2 mRNA or the ChAdOx-nCOV-19 COVID-19 vaccines
por: Chan, Wei Yee, et al.
Publicado: (2021) -
Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors
por: Chan, Wei Yee, et al.
Publicado: (2021) -
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
por: Lecat, Catherine S. Y., et al.
Publicado: (2021) -
PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE IN 653 PATIENTS.
por: Kanellias, Nikolaos, et al.
Publicado: (2023)